NCI-designated Cancer Centers Urge HPV Vaccination for the Prevention of Cancer

Approximately 79 million people in the United States are currently infected with a human papillomavirus (HPV) according to the Centers for Disease Control and Prevention (CDC), and 14 million new infections occur each year. Several types of high-risk HPV are responsible for the vast majority of cervical, anal, oropharyngeal (middle throat) and other genital cancers. …


Jefferson Liver Tumor Center Video Blog: Dr. Cataldo Doria

The Jefferson Liver Tumor Center is a multidisciplinary collaboration of hepatologists, interventional and imaging radiologists, surgeons, medical and radiation oncologists, anesthesiologists, nurse practitioners, social workers, transplant coordinators, and specialists in integrative medicine. Dr. Cataldo Doria, the Center’s surgical director, shares some information on its services, and how it helps patients with liver diseases and liver …


TJU Researchers Find Link Between Obesity and Increased Risk of Colorectal Cancer

Thomas Jefferson University scientists say the culprit is excess calories, but risk can be reversed through lifestyle modification or, potentially, use of an approved drug. Obesity has long been associated with increased risk of colorectal cancer, but the link has never been understood.Now, a research team led by investigators at Thomas Jefferson University has revealed the …


Dr. Kelly featured in the Inquirer regarding Moonshot Announcement

Vice President Biden met with scientists at the University of Pennsylvania’s Abramson Cancer Center Friday afternoon, officially launching his “moonshot” quest to cure cancer. “We’re on the cusp of phenomenal breakthroughs,” Biden said, adding that President Obama would be issuing an executive order that would get every federal agency involved in the effort. “There are …


Three Hits to Fight Lung Cancer

In experimental models of lung cancer, researchers show that a combo of two drugs plus radiation could make a subset of treatment-resistant lung cancers susceptible to therapy. (PHILADELPHA) – Although the most common type of lung cancer – non-small cell lung cancer (NSCLC) – has recently seen major treatment advances in some genetic subtypes, other …


SKCC Member receives R21 Grant

Dr Isidore Rigoutsos, PhD Director of Computational Medicine Center: Cancer Biology, Pathology, Anatomy and Cell Biology for the Sidney Kimmel Cancer Center and Professor Biochemistry & Molecular Biology was recently awarded an R21 grant for the Discovery of Novel miRNAs and isomiRs and Use in Sub-typing TCGA cancers.  Summary Statement from Dr. Rigoutsos: Recently, we …


Atezolizumab Could Change Standard of Care in Metastatic Urothelial Cancers

“This primary analysis of IMvigor 210 demonstrated that atezolizumab has the potential to change the standard of care for metastatic urothelial cancers.” – Jean H. Hoffman-Censits, MD Second-line treatment with atezolizumab (MPDL3280A) resulted in a median overall survival (OS) of 11.4 months in patients with locally advanced or metastatic urothelial carcinoma (mUC) and who showcased …


SKCC Researcher Named one of 3 New Outrun the Sun Melanoma Research Scholars

  OUTRUN THE SUN NAMES THREE NEW MELANOMA RESEARCH SCHOLARS Jessica Teh, Post Doc Fellow – Dr. Andrew Aplin Lab Indianapolis: Outrun the Sun, Inc., (www.outrunthesun.org) a nonprofit organization supporting skin cancer education and melanoma research, welcomes three new melanoma researchers to the Outrun the Sun Melanoma Research Scholar Program. The 2015 Scholars are: Brian …


Saving Eyes, Saving Vision

A Neurosurgeon and an Oncologist Join Forces to Treat a Childhood Eye Cancer   IN 2011, LEANNE DAVIS, a new mom and high school English teacher from Warren, Mich., took her 4-month-old son Cole with her to her regular eye exam. As a child, Leanne had retinoblastoma, a rare and potentially deadly cancer of the …


Two SKCC PhD Students Invited To Present Research At International Meetings

Congratulations to two PhD students in Dr. Karen Knudsen’s laboratory who have been invited to speak at upcoming Keystone Symposia on Molecular and Cellular Biology!! Jennifer Jones McMann, a student in the Genetics, Genomics and Cancer Biology PhD Program, will present “Novel Action of p53 Gain-of-Function Mutation in Prostate Cancer Progression” at the Keystone Conference …


Dr. Robert Den featured on eCancerTV

Dr Den talks to ecancertv at ASTRO 2015 about a study that found a commercially available genomic classifier for prostate cancer may be able to help predict which men may benefit from additional systemic therapy after prostatectomy and salvage radiotherapy. In the interview he describes how the test was able to predict which men would …

Page 1 of 23